DDW 2022 Conference Coverage


 

An Update on the Long-Term Safety and Efficacy of Ustekinumab in Bionaive Patients With Crohn's Disease and Ulcerative Colitis

263 views
June 7, 2022
Comments 0
Login to view comments. Click here to Login